Tags

Type your tag names separated by a space and hit enter

Katayama syndrome.
Lancet Infect Dis. 2007 Mar; 7(3):218-24.LI

Abstract

Katayama syndrome is an early clinical manifestation of schistosomiasis that occurs several weeks post-infection with Schistosoma spp (trematode) worms. Because of this temporal delay and its non-specific presentation, it is the form of schistosomiasis most likely to be misdiagnosed by travel medicine physicians and infectious disease specialists in non-endemic countries. Katayama syndrome appears between 14-84 days after non-immune individuals are exposed to first schistosome infection or heavy reinfection. Disease onset appears to be related to migrating schistosomula and egg deposition with individuals typically presenting with nocturnal fever, cough, myalgia, headache, and abdominal tenderness. Serum antibodies and schistosome egg excretion often substantiate infection if detected. Diffuse pulmonary infiltrates are found radiologically, and almost all cases have eosinophilia and a history of water contact 14-84 days before presentation of clinical symptoms; patients respond well to regimens of praziquantel with and without steroids. Artemisinin treatment given early after exposure may decrease the risk of the syndrome.

Authors+Show Affiliations

Department of Community Health and Epidemiology, College of Medicine, University of Saskatchewan, Saskatoon, Canada. allen.ross@usask.caNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't
Review

Language

eng

PubMed ID

17317603

Citation

Ross, Allen G., et al. "Katayama Syndrome." The Lancet. Infectious Diseases, vol. 7, no. 3, 2007, pp. 218-24.
Ross AG, Vickers D, Olds GR, et al. Katayama syndrome. Lancet Infect Dis. 2007;7(3):218-24.
Ross, A. G., Vickers, D., Olds, G. R., Shah, S. M., & McManus, D. P. (2007). Katayama syndrome. The Lancet. Infectious Diseases, 7(3), 218-24.
Ross AG, et al. Katayama Syndrome. Lancet Infect Dis. 2007;7(3):218-24. PubMed PMID: 17317603.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Katayama syndrome. AU - Ross,Allen G, AU - Vickers,David, AU - Olds,G Richard, AU - Shah,Syed M, AU - McManus,Donald P, PY - 2007/2/24/pubmed PY - 2007/3/21/medline PY - 2007/2/24/entrez SP - 218 EP - 24 JF - The Lancet. Infectious diseases JO - Lancet Infect Dis VL - 7 IS - 3 N2 - Katayama syndrome is an early clinical manifestation of schistosomiasis that occurs several weeks post-infection with Schistosoma spp (trematode) worms. Because of this temporal delay and its non-specific presentation, it is the form of schistosomiasis most likely to be misdiagnosed by travel medicine physicians and infectious disease specialists in non-endemic countries. Katayama syndrome appears between 14-84 days after non-immune individuals are exposed to first schistosome infection or heavy reinfection. Disease onset appears to be related to migrating schistosomula and egg deposition with individuals typically presenting with nocturnal fever, cough, myalgia, headache, and abdominal tenderness. Serum antibodies and schistosome egg excretion often substantiate infection if detected. Diffuse pulmonary infiltrates are found radiologically, and almost all cases have eosinophilia and a history of water contact 14-84 days before presentation of clinical symptoms; patients respond well to regimens of praziquantel with and without steroids. Artemisinin treatment given early after exposure may decrease the risk of the syndrome. SN - 1473-3099 UR - https://www.unboundmedicine.com/medline/citation/17317603/Katayama_syndrome_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S1473-3099(07)70053-1 DB - PRIME DP - Unbound Medicine ER -